Trade Adaptive Biotechnologies Corporation - ADPT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.33 |
| Open | 4.45 |
| 1-Year Change | -43.02% |
| Day's Range | 4.34 - 4.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 4.32 | 0.27 | 6.67% | 4.05 | 4.50 | 4.05 |
| Jul 24, 2024 | 4.14 | 0.09 | 2.22% | 4.05 | 4.29 | 4.05 |
| Jul 23, 2024 | 4.17 | 0.09 | 2.21% | 4.08 | 4.30 | 4.08 |
| Jul 22, 2024 | 4.13 | 0.12 | 2.99% | 4.01 | 4.14 | 3.92 |
| Jul 19, 2024 | 4.01 | -0.14 | -3.37% | 4.15 | 4.21 | 4.00 |
| Jul 18, 2024 | 4.21 | -0.05 | -1.17% | 4.26 | 4.47 | 4.10 |
| Jul 17, 2024 | 4.32 | -0.01 | -0.23% | 4.33 | 4.63 | 4.25 |
| Jul 16, 2024 | 4.43 | 0.43 | 10.75% | 4.00 | 4.52 | 4.00 |
| Jul 15, 2024 | 4.00 | 0.01 | 0.25% | 3.99 | 4.11 | 3.92 |
| Jul 12, 2024 | 3.97 | 0.11 | 2.85% | 3.86 | 4.14 | 3.86 |
| Jul 11, 2024 | 3.87 | 0.36 | 10.26% | 3.51 | 3.91 | 3.49 |
| Jul 10, 2024 | 3.48 | 0.04 | 1.16% | 3.44 | 3.53 | 3.44 |
| Jul 9, 2024 | 3.52 | -0.06 | -1.68% | 3.58 | 3.61 | 3.45 |
| Jul 8, 2024 | 3.60 | 0.09 | 2.56% | 3.51 | 3.64 | 3.49 |
| Jul 5, 2024 | 3.52 | 0.26 | 7.98% | 3.26 | 3.59 | 3.26 |
| Jul 3, 2024 | 3.36 | 0.06 | 1.82% | 3.30 | 3.40 | 3.28 |
| Jul 2, 2024 | 3.35 | -0.16 | -4.56% | 3.51 | 3.57 | 3.32 |
| Jul 1, 2024 | 3.58 | -0.06 | -1.65% | 3.64 | 3.70 | 3.46 |
| Jun 28, 2024 | 3.60 | 0.11 | 3.15% | 3.49 | 3.62 | 3.44 |
| Jun 27, 2024 | 3.44 | 0.13 | 3.93% | 3.31 | 3.45 | 3.25 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Adaptive Biotechnologies Corporation Company profile
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Adaptive Biotechnologies Corp revenues increased 57% to $154.3M. Net loss increased 42% to $207.3M. Revenues reflect Sequencing revenue segment increase of 90% to $78.9M, Development revenue segment increase of 32% to $75.4M. Higher net loss reflects Research and development - Balancing increase of 19% to $128.3M (expense), General and administrative - Balancing increase of 47% to $59.7M (expense).
| Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com